drugset / Trial / NCT00645073

Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

NCT00645073

Phase 4 Completed 271 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the safety and efficacy of a ten-day course of therapy of cefdinir, 600 mg QD, to a ten-day course of therapy of levofloxacin, 500 mg QD, in the treatment of acute bacterial sinusitis.

Timeline

Start
2003-11
Primary completion
2004-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levofloxacin Small molecule 500 mg
Comparator cefdinir Other / unclassified 600 mg

Indications